Advertisement

Biochemical Genetics

, 49:601 | Cite as

Molecular Characterization of Factor V Leiden G1691A and Prothrombin G20210A Mutations in Saudi Newborns with Stroke

  • Gihan E-H. GawishEmail author
Article

Abstract

This study examined a possible association between the mutations related to Factor V Leiden and Factor II (prothrombin) and stroke in Saudi neonates. A multiplex PCR was established to detect Factor V Leiden G1691A and prothrombin G20210A mutations in 72 neonatal stroke subjects and 70 healthy adult controls with no family history of thromboembolic diseases. The frequency of the homozygous normal genotype (GG) of both genes was found to be significantly lower in the stroke subjects than in the controls (P < 0.0001). The stroke cases also had higher frequencies of the combined Factor II heterozygous mutant form (GA) and the homozygous normal Factor V (GG) (P < 0.0001) and of the combined heterozygous Factor V and the homozygous normal Factor II genotypes (GG) (P = 0.0) than controls. The study concluded that prothrombin and Factor V Leiden may be important risk factors for neonatal stroke in Saudi children.

Keywords

Neonatal stroke Factor V Leiden Factor II Prothrombin 

Notes

Acknowledgments

I would like to thank the Research Center, Female Center for Scientific and Medical Colleges, King Saud University for their kind help. This study was supported by the Research Center - Female Centre for Scientific and Medical Colleges, and Genome Research Chair, King Saud University.

References

  1. Akar N, Akar E, Ozel D, Deda G, Sipahi T (2001) Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 15:115–120CrossRefGoogle Scholar
  2. Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M (1999) Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and Factor V genes. Thromb Haemost 81:506–510PubMedGoogle Scholar
  3. Awada A, Rajeh S, Ammar A, Adeyokunnu A (1994) Stroke in children: a study of 21 cases from Saudi Arabia. Ann Trop Paediatr 14:131–135PubMedGoogle Scholar
  4. Biswas R, Ranjan A, Meena S, Akhter V, Sharma BK, Yadav M, Behari R (2009) Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thromb Res 124:397–402PubMedCrossRefGoogle Scholar
  5. Buchanan GS, Rodgers GM, Branch DW (2003) The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Pract Res Clin Obstet Gynecol 17:397–411CrossRefGoogle Scholar
  6. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Mannucci PM (1997) A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant Factor V (Factor V: Q506). Arterioscler Thromb Vasc Biol 17:1662–1666PubMedCrossRefGoogle Scholar
  7. Dahlback B (2005) Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 257:209–223PubMedCrossRefGoogle Scholar
  8. Doyle NM, Monga M (2004) Thromboembolic disease in pregnancy. Obstet Gynecol Clin N Am 31:319–344CrossRefGoogle Scholar
  9. Duran R, Biner B, Demir M, Celtik C, Karasalihoğlu S (2005) Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 11:83–88PubMedCrossRefGoogle Scholar
  10. Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G (2006) Inherited thrombophilia. Crit Rev Clin Lab Sci 43:249–290PubMedCrossRefGoogle Scholar
  11. Goodman S, Pavlakis S (2008) Pediatric and newborn stroke. Curr Treat Options Neurol 10:431–439PubMedCrossRefGoogle Scholar
  12. Hong SH (2003) Genotype distribution of the mutations in the coagulation Factor V gene in the Korean population: absence of its association with coronary artery disease. Korean J Biol Sci 7:255–259CrossRefGoogle Scholar
  13. Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, Chabrier S, Chan A, deVeber G, Fiedler B, Fullerton HJ, Goldenberg NA, Grabowski E, Günther G, Heller C, Holzhauer S, Iorio A, Journeycake J, Junker R, Kirkham FJ, Kurnik K, Lynch JK, Male C, Manco-Johnson M, Mesters R, Monagle P, van Ommen CH, Raffini L, Rostásy K, Simioni P, Sträter RD, Young G, Nowak-Göttl U (2010) Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 121:1838–1847PubMedCrossRefGoogle Scholar
  14. Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517–1532PubMedGoogle Scholar
  15. Mannucc PM (2005) Laboratory detection of inherited thrombophilia: a historical perspective. Sem Thromb Hemost 315:10Google Scholar
  16. Miller SP, Wu YW, Lee J, Lammer EJ, David M, Iovannisci DM, Glidden DV, Bonifacio SL, Collins A, Shaw GM, Barkovich AJ, Ferriero DM (2006) Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke 37:2678PubMedCrossRefGoogle Scholar
  17. NINDS (2005) Spina bifida fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/spina_bifida/detail_spina_bifida.htm
  18. Nowak-Göttl U, Kosch A, Schlegel N (2001) Thromboembolism in newborns, infants and children. Thromb Haemost 86:464–474PubMedGoogle Scholar
  19. Ranguelov RD, Rosenthal N, Bromley C, Vasef MA (2002) Detection of Factor V Leiden and prothrombin gene mutations in patients who died with thrombotic events. Arch Pathol Lab Med 126:1193–1196PubMedGoogle Scholar
  20. Reiner AP, Siscovick DS, Rosendaal FR (2001) Hemostatic risk factors and arterial thrombotic disease. Thromb Haemost 85:584–595PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Biochemistry Department, Faculty of Science, Female Centre for Scientific and Medical CollegesKing Saud UniversityRiyadhKingdom of Saudi Arabia

Personalised recommendations